What is the management of shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Shock

The management of shock requires a standardized approach focused on rapid diagnosis, early intervention, ongoing hemodynamic assessment, and multidisciplinary longitudinal care to reduce mortality rates that currently exceed 40%. 1

Diagnosis and Initial Assessment

  • Shock diagnosis requires systolic blood pressure <90 mmHg for 30 minutes or requiring vasopressors to maintain SBP >90 mmHg, evidence of end-organ hypoperfusion, and lactate >2 mmol/L 1, 2
  • Hemodynamic criteria include cardiac index <1.8 L/min/m² without vasopressors/inotropes and cardiac power output <0.6 W 1, 2
  • Early invasive hemodynamic assessment using pulmonary artery catheter (PAC) is recommended to guide therapy and identify specific shock phenotypes 1, 2
  • Immediate comprehensive assessment with ECG and echocardiography is essential for all patients with suspected shock 2

Initial Management Steps

  • Perform fluid challenge (saline or Ringer's lactate, >200 ml/15-30 min) as first-line treatment if there are no signs of overt fluid overload 2
  • Ensure adequate oxygenation and ventilation, considering early intubation for respiratory distress 1
  • Implement a multidisciplinary shock team approach with standardized protocols for complex cases 3, 1, 2

Pharmacological Management

  • Norepinephrine is the preferred first-line vasopressor when mean arterial pressure needs pharmacologic support 1, 2, 4
  • Initial norepinephrine dosing typically starts at 2-3 mL (8-12 mcg of base) per minute, with maintenance doses averaging 0.5-1 mL (2-4 mcg of base) per minute 4
  • Titrate vasopressors to maintain low normal blood pressure (usually 80-100 mmHg systolic) sufficient to maintain vital organ perfusion 4
  • Dobutamine (2-20 μg/kg/min) is the first-line inotropic agent to increase cardiac output in cardiogenic shock 1, 2
  • For left ventricular-dominant cardiogenic shock with normotensive hypoperfusion, consider pure vasodilators like nitroprusside to improve cardiac output by reducing afterload 1

Type-Specific Management

Cardiogenic Shock

  • Early revascularization is crucial for acute myocardial infarction with cardiogenic shock 1, 2
  • Consider mechanical circulatory support (MCS) in refractory shock based on cardiac index <2.2 L/min/m², cardiac power output <0.6 W, and persistent lactate elevation despite initial therapy 1, 2
  • Routine use of intra-aortic balloon pump (IABP) is not recommended 2

Septic Shock

  • Norepinephrine is the preferred vasopressor 1
  • Consider vasopressin or angiotensin II for their norepinephrine-sparing effects 1
  • Ensure early appropriate antibiotic therapy 5

Right Ventricular Failure

  • Minimize intrathoracic positive pressure ventilation, correct acidosis, and improve oxygenation 1
  • Maintain adequate preload while avoiding volume overload 1

Advanced Care Considerations

  • Transfer patients with shock to a tertiary care center with 24/7 cardiac catheterization capability and mechanical circulatory support availability when appropriate 3, 2
  • Level 1 shock centers with full spectrum capabilities provide optimal outcomes for complex shock cases 3, 1
  • Ongoing hemodynamic assessment and titration of therapies to the minimal efficacious dose is essential 1
  • When administering norepinephrine, avoid abrupt withdrawal and reduce gradually as the patient stabilizes 4

Special Considerations for Older Adults

  • Management of shock in older adults requires an individualized risk assessment approach considering age-associated risks and goals of care 3
  • Decision-making should involve patient factors, clinical trajectory, and center capabilities when determining escalation or de-escalation of care 3
  • An interdisciplinary approach is crucial for optimizing outcomes in older adults with shock 3

Monitoring and Reassessment

  • Continuous bedside evaluation, resuscitation, and re-evaluation is required as shock is a dynamic condition 6
  • Monitor for signs of multiple-system organ failure, which can develop from prolonged shock of any cause 6
  • Continually reassess as one shock state may convert to another, requiring adjustment of management strategies 5

References

Guideline

Management of Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Cardiogenic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The evaluation and management of shock.

Clinics in chest medicine, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.